Bill Baumel

Bill Baumel has been involved in a variety of venture capital and technology companies since 2016. In that time, they have held the role of Managing Director at Ohio Innovation Fund, Director at Clarametyx Biosciences, ScriptDrop, DAtAnchor Inc., eFuse, Investor at Alviere, Director at Aware, Investor and Advisor at Immuta, Director at Genetesis, and Director at Stirling Ultracold, Division of Global Cooling, Inc. Baumel has leveraged their past VC experience in Silicon Valley, which spans more than 20 years, to provide valuable market insights and expertise in business strategy, product, financing options, and management team building. Bill has been featured in prominent media such as CNN, Forbes, CNBC, and The Wall Street Journal.

Bill Baumel obtained a Certificate in Leadership Principles from Harvard Business School Online in 2020. From 1992 to 1994, they obtained an MBA with High Distinction from the University of Michigan - Stephen M. Ross School of Business, with a focus in Finance, Strategy, and Marketing. Between 1986 and 1990, they obtained a BS with Summa cum laude from The Ohio State University, with an Honors focus in Accounting & Economics. Additionally, they hold a Certified Public Accountant certification.